BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34696358)

  • 1. Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas.
    Barh D; Tiwari S; Gabriel Rodrigues Gomes L; Weener ME; Alzahrani KJ; Alsharif KF; Aljabali AAA; Tambuwala MM; Lundstrom K; Hassan SS; Serrano-Aroca Á; Takayama K; Ghosh P; Redwan EM; Silva Andrade B; Soares SC; Azevedo V; Uversky VN
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation.
    Miao G; Zhao H; Li Y; Ji M; Chen Y; Shi Y; Bi Y; Wang P; Zhang H
    Dev Cell; 2021 Feb; 56(4):427-442.e5. PubMed ID: 33422265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein.
    Tan TH; Patton E; Munro CA; Corzo-Leon DE; Porter AJ; Palliyil S
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library.
    Kim YJ; Lee MH; Lee SR; Chung HY; Kim K; Lee TG; Kim DY
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.
    Drouin AC; Theberge MW; Liu SY; Smither AR; Flaherty SM; Zeller M; Geba GP; Reynaud P; Rothwell WB; Luk AP; Tian D; Boisen ML; Branco LM; Andersen KG; Robinson JE; Garry RF; Fusco DN
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34201591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
    Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
    F1000Res; 2020; 9():576. PubMed ID: 32802318
    [No Abstract]   [Full Text] [Related]  

  • 9. Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice.
    Mamedov T; Yuksel D; Ilgın M; Gurbuzaslan I; Gulec B; Yetiskin H; Uygut MA; Islam Pavel ST; Ozdarendeli A; Mammadova G; Say D; Hasanova G
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites.
    Lechuga GC; Souza-Silva F; Sacramento CQ; Trugilho MRO; Valente RH; Napoleão-Pêgo P; Dias SSG; Fintelman-Rodrigues N; Temerozo JR; Carels N; Alves CR; Pereira MCS; Provance DW; Souza TML; De-Simone SG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain.
    Yang J; Zhang Z; Yang F; Zhang H; Wu H; Zhu F; Xue W
    Chem Biol Drug Des; 2021 Jul; 98(1):1-18. PubMed ID: 33894099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 ORF3a positively regulates NF-κB activity by enhancing IKKβ-NEMO interaction.
    Nie Y; Mou L; Long Q; Deng D; Hu R; Cheng J; Wu J
    Virus Res; 2023 Apr; 328():199086. PubMed ID: 36894068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor.
    Treewattanawong W; Sitthiyotha T; Chunsrivirot S
    Sci Rep; 2021 Nov; 11(1):22202. PubMed ID: 34772947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses.
    Kumar R; Christensen ND; Kaddis Maldonado RJ; Bewley MC; Ostman A; Sudol M; Chen EC; Buchkovich NW; Gontu A; Surendran Nair M; Nissly RH; Minns AM; Kapur V; Rossi R; Kuchipudi SV; Lindner SE; Parent LJ; Flanagan JM; Buchkovich NJ
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
    Choudhary S; Malik YS; Tomar S
    Front Immunol; 2020; 11():1664. PubMed ID: 32754161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.
    Bell BN; Powell AE; Rodriguez C; Cochran JR; Kim PS
    Protein Sci; 2021 Apr; 30(4):716-727. PubMed ID: 33586288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication.
    Gowda P; Patrick S; Joshi SD; Kumawat RK; Sen E
    Cytokine; 2021 Jun; 142():155496. PubMed ID: 33773396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 ORF3a-Mediated NF-κB Activation Is Not Dependent on TRAF-Binding Sequence.
    Busscher BM; Befekadu HB; Liu Z; Xiao TS
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.
    Fu D; Zhang G; Wang Y; Zhang Z; Hu H; Shen S; Wu J; Li B; Li X; Fang Y; Liu J; Wang Q; Zhou Y; Wang W; Li Y; Lu Z; Wang X; Nie C; Tian Y; Chen D; Wang Y; Zhou X; Wang Q; Yu F; Zhang C; Deng C; Zhou L; Guan G; Shao N; Lou Z; Deng F; Zhang H; Chen X; Wang M; Liu L; Rao Z; Guo Y
    PLoS Biol; 2021 May; 19(5):e3001209. PubMed ID: 33961621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
    Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.